Latest News


Merck claims win in Texas lawsuit over Vioxx

Fort Worth Star-Telegram (Texas) | 11 hours 3 minutes ago

The Associated Press WHITEHOUSE STATION, N.J. ? Merck & Co.... (more)


GlaxoSmithKline Halts H1N1 Vaccinations In Canada

Modern Materials Handling | 11 hours 4 minutes ago

WASHINGTON (Kyodo) -- British drug maker GlaxoSmithKline Plc. is suspending the use of 170,000 doses of its new H1N1 influenza vaccine in Canada given a higher-than-usual rate of reported side effects, Canadian media reported Monday.... (more)


Boston Scientific to leave Doral

American City Business Journals | 11 hours 7 minutes ago

Medical products company Boston Scientific Corp., which has more than 1,200 employees working out of a 14-acre plant in Doral, is relocating its operation to Costa Rica over the next three years.... (more)


iBasis, Tower Semi: Early Volume Plays

TheStreet.com | 11 hours 10 minutes ago

NEW YORK (TheStreet) -- Several stocks trading under $5 were poised to move on above-average volume during Monday's session.... (more)


Mixed results from Ception, Cephalon on Cinquil

American City Business Journals | 11 hours 11 minutes ago

Ception Therapeutics Inc. and Cephalon Inc. announced mixed results Monday for late-stage testing of Cinquil, an experimental drug the two suburban Philadelphia biotechnology companies are developing to treat pediatric eosinophilic esophagitis.... (more)


UPDATE 1-Texas court tosses state Vioxx suit against Merck

Reuters | 11 hours 15 minutes ago

NEW YORK, Nov 23 (Reuters) - A Texas court has dismissed a lawsuit brought by the state against drugmaker Merck & Co (MRK.N) that sought a refund for money spent on the withdrawn Vioxx pain treatment, the company said on Monday.... (more)


UPDATE 1-Cephalon delays Ception deal after mixed drug data

Reuters | 11 hours 15 minutes ago

BOSTON, Nov 23 (Reuters) - Cephalon Inc (CEPH.O) said on Monday that an experimental drug for a rare type of inflammation of the esophagus showed mixed results in a mid-to-late stage clinical trial, sending its shares down more than 9 percent.... (more)


Spray can prevent premature ejaculation: study

Yahoo! | 11 hours 16 minutes ago

WASHINGTON (Reuters) ? A spray that numbs the penis can help prevent premature ejaculation, doctors reported on Thursday, and drug maker Sciele Pharma Inc, a division of Japan's Shionogi, plans to file for U.S. approval next year.... (more)


Recovery School District repair allocation OK'd

Education Week (premium article access compliments of EdWeek.org) | 11 hours 17 minutes ago

BATON ROUGE, La. (AP) Several lawmakers expressed their displeasure about how it's run, but a legislative budget committee finally agreed to let the Recovery School District move ahead with $163 million in repairs to hurricane-damaged schools in New Orleans.... (more)


Astex Therapeutics gains orphan approval in US and Europe

Business Weekly (U.K.) | 12 hours 21 minutes ago

Astex Therapeutics, fresh from a multi-million pound deal with GSK, has announced that it has been granted orphan drug designation in Europe and the US for its treatment of patients with Acute Myeloid Leukaemia (AML).... (more)


UPDATE 1-Spectrum inks deal with Korea's Handok for cancer drug

Reuters | 12 hours 21 minutes ago

Nov 23 (Reuters) - Spectrum Pharmaceuticals Inc (SPPI.O) said Handok Pharmaceuticals Co Ltd (002390.KS) will develop and commercialize Spectrum's experimental cancer drug in South Korea as part of a deal valued at more than $19 million.... (more)




...  5  6  7  8  9  10  11  12  13 ...   Next >

419 Stories  |   RSS Feed



Sign up for AANP SmartBrief



Designed specifically for nurse practitioners and health care professionals like you, AANP SmartBrief is a FREE daily e-mail newsletter. It provides the latest news and information you need to stay informed about important health care issues. Learn more

Latest Blog Postsview more


Companies in the news